Conference - Tel Aviv, Israel
Breast cancer in young women is a devastating and complex disease. Breast cancer in women under 40 strikes when these women are at the peak of their reproductive years, family life and careers and still have many years ahead of them to suffer the long-term effects of treatment or the consequences of recurrent disease. The etiology of breast cancer in this population is poorly understood and most clinical trials focus on women who are over the age of 40, thus little evidence-based data is available about the optimal management of these patients. Further research is much needed in this field. This conference is an opportunity for the latest updates on this field and a platform for generating future research concepts and collaborations. It will cover epidemiology, molecular biology, genetics, pathology, surgery, radiotherapy, systemic therapy and fertility preservation in young women with breast cancer.
- Organization: European School of Oncology (ESO)
- 2nd Breast Cancer in Young Women Conference (BCY2)
Thu, Nov 06, 2014 - Fri, Nov 07, 2014
Hilton Tel Aviv Hotel
Independence Park, Tel Aviv, Israel
-
-
If you'd like to ask a question or post a comment about this talk please do so below.This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
